Implementing automation involves careful optimization and fine-tuning of various parameters to ensure the accurate execution of cell-based potency assays.
Webinar Date/Time: Thu, Apr 25, 2024 11:00 AM EDT
Webinar Date/Time: Wed, May 8, 2024 11:00 AM EDT
Webinar Date/Time: Wed, Feb 28, 2024 11:00 AM EST
Webinar Date/Time: Thu, Dec 14, 2023 11:00 AM EST
Shorten clinical development timeline using novel GPEx® Lightning cell line development technology.
CDMO Catalent’s UpTempo℠ adeno-associated viral (AAV) platform process accelerates time from gene to clinic.
Catalent provides fill/finish services in a range of formats to support clinical and commercial products.
Shorten clinical development timeline using novel GPEx® Lightning technology